Veterinary Dermatology

Papers
(The TQCC of Veterinary Dermatology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Advances in our understanding of canine atopic dermatitis34
Clinical signs and diagnosis of feline atopic syndrome: detailed guidelines for a correct diagnosis27
Wound healing in animals: a review of physiology and clinical evaluation25
Feline allergic diseases: introduction and proposed nomenclature23
Treatment of the feline atopic syndrome – a systematic review18
Antimicrobial susceptibility monitoring of canine and feline skin and ear pathogens isolated from European veterinary clinics: results of the ComPath Surveillance programme14
A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long‐term control of dogs with nonseasonal atopic dermatitis14
Immunopathogenesis of the feline atopic syndrome12
Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus12
Beneficial effect of oclacitinib in a case of feline pemphigus foliaceus12
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis12
Treatment complexity and caregiver burden are linked in owners of dogs with allergic/atopic dermatitis12
Prolonged twice‐daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client‐owned atopic dogs12
A moisturizer formulated with glycerol and propylene glycol accelerates the recovery of skin barrier function after experimental disruption in dogs11
Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus10
A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris10
A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis9
Topical treatment of equine sarcoids with imiquimod 5% cream or Sanguinaria canadensis and zinc chloride – an open prospective study9
Multivariable analysis of the influence of cross‐reactive carbohydrate determinant inhibition and other factors on intradermal and serological allergen test results: a prospective, multicentre study8
Immunomodulatory effect of long‐term oclacitinib maleate therapy in dogs with atopic dermatitis8
Discrepancies in the bilateral intradermal test and serum tests in atopic horses8
Detection and Inhibition of IgE for cross‐reactive carbohydrate determinants evident in an enzyme‐linked immunosorbent assay for detection of allergen‐specific IgE in the sera of dogs and cats8
Management of canine perianal fistula with fluorescence light energy: preliminary findings8
Serum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis8
Caregiver burden, treatment complexity, and the veterinarian–client relationship in owners of dog with skin disease8
Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases7
Characterization of canine epidermal organoid cultures by immunohistochemical analysis and quantitative PCR7
Sensitivity and specificity of a shortened elimination diet protocol for the diagnosis of food‐induced atopic dermatitis (FIAD)7
The skin microbiota in equine pastern dermatitis: a case‐control study of horses in Switzerland7
Whole genome sequencing and de novo assembly of Staphylococcus pseudintermedius: a pangenome approach to unravelling pathogenesis of canine pyoderma7
Effect of an anti‐inflammatory pomegranate otic treatment on the clinical evolution and microbiota profile of dogs with otitis externa7
Extensive progressive pigmented viral plaques in a Chihuahua dog7
Malassezia otitis unresponsive to primary care: outcome in 59 dogs7
Clinical Techniques: When and how to do a myringotomy – a practical guide7
Shortened immunotherapy dose‐escalation saves time, but is it safe? A case‐control study comparing the rates of adverse reactions between conventional and fast‐escalation subcutaneous immunotherapy pr6
Cases of dermatophytosis caused by Trichophyton benhamiae var. luteum and T. europaeum, newly described dermatophytes within the T. benhamiae complex6
Ichthyosis and hereditary cornification disorders in dogs6
Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double‐blinded, placebo‐controlled tria6
Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases6
Feline bilateral inflammatory aural polyps: a descriptive retrospective study6
Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome6
In vitro antimicrobial activity of cold atmospheric microwave plasma against bacteria causing canine skin and ear infections6
A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus6
Local wound management: A review of modern techniques and products6
Dermatophytosis with concurrent Trichophyton verrucosum and T. benhamiae in calves after long‐term transport6
In vitro antibacterial and antibiofilm effects of cold atmospheric microwave plasma against Pseudomonas aeruginosa causing canine skin and ear infections6
A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine‐month controlled study5
Measurement of serum Interleukin 34 (IL‐34) and correlation with severity and pruritus scores in client‐owned dogs with atopic dermatitis5
Clinical efficacy of sublingual allergen‐specific immunotherapy in 22 cats with atopic dermatitis5
Evaluation of skin erythema severity by dermatoscopy in dogs with atopic dermatitis5
The upper epidermis of atopic dogs is altered at the functional and structural levels5
Canine pedal papilloma identification and management: a retrospective series of 44 cases5
Epithelial–immune crosstalk with the skin microbiota in homeostasis and atopic dermatitis – a mini review5
Venom immunotherapy for Hymenoptera allergy in a dog5
Efficacy of oral sarolaner against Lynxacarus radovskyi in naturally infested cats5
Veterinary allergy information has lower health readability than human allergy information: a comparative analysis of allergy education materials for pets and people5
Is low‐level laser therapy useful as an adjunctive treatment for canine acral lick dermatitis? A randomized, double‐blinded, sham‐controlled study5
Specific Dermatophagoides farinae extract for canine immunotherapy5
Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus)5
Influence of hospital size on antimicrobial resistance and advantages of restricting antimicrobial use based on cumulative antibiograms in dogs with Staphylococcuspseudintermedius infect5
A world of inflammation: the need for ecological solutions that co‐benefit people, place and planet5
Use of oclacitinib as antipruritic drug during sarcoptic mange infestation treatment5
The number of mitochondrial DNA mutations as a genetic feature for hair cycle arrest (alopecia X) in Pomeranian dogs5
Skin disease in goats (Capra aegagrus hircus): a retrospective study of 358 cases at a university veterinary teaching hospital (1988–2020)5
IL‐31 and IL‐31 receptor expression in acute experimental canine atopic dermatitis skin lesions5
Altered plasma cytokines in dogs with atopic dermatitis4
Detection and inhibition of IgE antibodies reactive with cross‐reactive carbohydrate determinants in an ELISA for allergen‐specific IgE in horses4
Carbon dioxide laser surgery for chronic proliferative and obstructive otitis externa in 26 dogs4
Preliminary evaluation of two bathing methods for the management of Malassezia overgrowth in dogs with atopic dermatitis4
The influence of clinical severity and topical antimicrobial treatment on bacteriological culture and the microbiota of equine pastern dermatitis4
Characterization of staphylococcal communities on healthy and allergic feline skin4
A randomised, double‐blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs4
Canine junctional epidermolysis bullosa due to a novel mutation in LAMA3 with severe upper respiratory involvement4
Oral dexamethasone sodium phosphate solution significantly reduces pruritus and clinical lesions in feline hypersensitivity dermatitis: an open‐label study4
Detection of circulating anti‐keratinocyte autoantibodies in feline pemphigus foliaceus4
Trunk‐dominant and classic facial pemphigus foliaceus in dogs – comparison of anti‐desmocollin‐1 and anti‐desmoglein‐1 autoantibodies and clinical presentations4
Clinical efficacy of spray‐based heat‐treated lactobacilli in canine atopic dermatitis: a preliminary, open‐label, uncontrolled study4
Probable cutaneous adverse drug reaction due to a cannabidiol‐containing hemp oil product in a dog4
Brachycephaly in French bulldogs and pugs is associated with narrow ear canals4
Atopic dermatitis in West Highland white terriers – Part III: early life peripheral blood regulatory T cells are reduced in atopic dermatitis4
Ear tip ulcerative dermatitis treated with oclacitinib in 25 dogs: a retrospective case series4
Longitudinal study of the cutaneous microbiota of healthy horses4
Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists4
The nose is not enough: Multi‐site sampling is best for MRSP detection in dogs and households4
Furuncular myiasis caused by Dermatobiahominis in five cats and efficacy of topical fluralaner for its treatment4
Combined prick and patch tests for diagnosis of food hypersensitivity in dogs with chronic pruritus4
Preventive use of a topical anti‐inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota4
Cutaneous microRNA expression in healthy Labrador and Golden retrievers and retrievers with allergic and inflammatory skin diseases4
Long‐term recurrent, yet nonprogressive, pedal viral papillomas in a dog4
Survey of cytokines on ocular surfaces of atopic dogs by multiplex analysis using two sampling methods – a pilot study4
Evaluation of cutaneous and circulating (serum and exosomes) levels of chemokines (CCL17, CCL22, CCL27 and CCL28) in atopic dogs and their correlation with 4
Grainyhead‐like transcription factors: guardians of the skin barrier4
Strain elastography for the assessment of skin nodules in dogs4
Transient and reversible reduction of stratum corneum filaggrin degradation products after allergen challenge in experimentally mite‐sensitised atopic dogs4
A study into the fatty acid content of selected veterinary diets, supplements and fish oil capsules in Australia3
The effect of topical lidocaine on intradermal testing in atopic dogs3
Local treatment for canine anal sacculitis: A retrospective study of 33 dogs3
Long‐term effects of ciclosporin and oclacitinib on mediators of tolerance, regulatory T‐cells, IL‐10 and TGF‐β, in dogs with atopic dermatitis3
Hair follicle dystrophy in a litter of domestic cats resembling lanceolate hair mutant mice3
Weekly topical therapy based on plant extracts combined with lokivetmab in canine atopic dermatitis3
Persistent activation of the mammalian target of rapamycin signalling pathway in cutaneous squamous cell carcinomas in cats3
Hyperkeratotic erythema multiforme variant in 17 dogs3
Treatment of canine cutaneous epitheliotropic T‐cell lymphoma with oclacitinib: a case report3
Alopecias in humans: biology, pathomechanisms and emerging therapies3
Results of food challenge in dogs with cutaneous adverse food reactions3
Evaluation of cold atmospheric microwave plasma on skin physiological parameters and tolerability in dogs3
Pyogranulomatous panniculitis in a domestic cat associated with Pseudomonas luteola infection3
Progression of aural plaques to squamous cell carcinoma in a horse3
Pseudomonas aeruginosa isolation from dog grooming products used by private owners or by professional pet grooming salons: prevalence and risk factors3
Efficacy of three disinfectant formulations and a hydrogen peroxide/silver fogging system on surfaces experimentally inoculated with meticillin‐resistant Staphylococcus pseudintermedius3
Staphylococci isolated from cats in Italy with superficial pyoderma and allergic dermatitis: Characterisation of isolates and their resistance to antimicrobials3
Preliminary study of the stability of dexamethasone when added to commercial veterinary ear cleaners over a 90 day period3
Retrospective case series: Necrotising fasciitis in 23 dogs3
A clinical retrospective study of Caparinia tripilis (Psoroptidae) mite dermatitis in pet African pygmy hedgehogs (Ateletrix albiventris) in southern Italy3
A randomised, double‐blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO‐524 in dogs with atopic dermatitis3
Development of multiple cutaneous and follicular neoplasms associated with canine papillomavirus type 3 in a dog3
0.031380891799927